Head of Investor Relations
Roivant Sciences Ltd. (ROIV)Equibles does not estimate personal net worth.
Get an email with a short summary when Roivant Sciences Ltd. publishes a filing, an earnings call transcript or a press release.
Get ROIV alertsStephanie Lee is recorded as Head of Investor Relations at Roivant Sciences Ltd. (ROIV). Stephanie Lee has spoken on 6 earnings calls across 1 company, most recently for Roivant Sciences Ltd. on November 9, 2026. Roivant Sciences Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Roivant Sciences Ltd. includes Eric Venker (CEO and COO), Matthew Gline (CEO and Board Member), Richard Pulik (CFO) and 7 others.
“Good morning, and thanks for joining today's call to review Roy Vance's second quarter ended September 30, 2022. I'm Stephanie Lee with Roy Vance. Presenting today, we have Matt Klein, CEO of Roy Vance.”
“Good morning, and thanks for joining today's call to review RoyBan's financial results for the first quarter ended June 30, 2026. I'm Stephanie Lee with RoyBan.”
“Good morning, and thanks for joining today's call to review business updates from Roy Vint's fourth quarter and fiscal year ended March 31, 2026. I'm Stephanie Lee with Roy Vint.”
“Good morning, and thanks for joining today's call to review positive Phase 2 results for breakfast whitnip and cutaneous sarcoidosis, and Roy Vance financial results for the third quarter ended December 31, 2025.”
“Good morning, and thanks for joining today's call to review business updates from Roy Vint's fourth quarter and fiscal year ended March 31, 2026. I'm Stephanie Lee with Roy Vint.”
Biotechnology · Healthcare
Head of Investor Relations
